Marla has more than 15 years of sales and marketing experience in the pharmaceutical industry. She has skillfully managed different aspects of strategic planning including market assessments of new competitive threats and investigational treatment techniques. Marla identifies trends within the biopharmaceutical environment and connects the dots to bring meaningful strategic interpretation of the changes shaping this industry.
Marla has worked in a several therapeutic classes, including dyslipidemia, hypertension, asthma, infectious disease, oncology as well as women’s and men’s health. As a marketer, she developed the strategic platform and tactical direction for a number of prescription medicines. Throughout her career, Marla has proven her ability to lead and motivate teams and to foster productive customer relationships both internally and externally.
As a consultant with Pangaea, Marla brings value to her clients by supporting their market research needs, investigating recent clinical data and creating useful communication tools.
Marla holds a Bachelor of Science in physiology from McGill University and an MBA from McMaster University. She is a regularly contributer to the OPMA Web site.
Areas of expertise
- Business Strategy
- Corporate Strategy
Recent articles by Marla Weingarten
Pangaea Express: PMPRB Notice and Comment
July 20, 2022
Pangaea Express: Quebec Releases Rare Disease Policy
July 15, 2022
Pangaea Express: PMPRB releases a statement, April 22, 2022
April 25, 2022
Pangaea Express: Supreme Court of Canada Dismisses Appeal in SOLIRIS case
March 28, 2022
Pangaea Express: Quebec Court of Appeal Case
February 25, 2022